Fazekas F - Search Results

1

Determinants of iron accumulation in deep grey matter of multiple sclerosis patients.

Ropele S, Kilsdonk ID, Wattjes MP, Langkammer C, de Graaf WL, Frederiksen JL, Larsson HB, Yiannakas M, Wheeler-Kingshott CA, Enzinger C, Khalil M, Rocca MA, Sprenger T, Amann M, Kappos L, Filippi M, Rovira A, Ciccarelli O, Barkhof F, Fazekas F. Ropele S, et al. Among authors: fazekas f. Mult Scler. 2014 Nov;20(13):1692-8. doi: 10.1177/1352458514531085. Epub 2014 Apr 30. Mult Scler. 2014. PMID: 24787429

2

CT and MRI rating of white matter lesions.

Fazekas F, Barkhof F, Wahlund LO, Pantoni L, Erkinjuntti T, Scheltens P, Schmidt R. Fazekas F, et al. Cerebrovasc Dis. 2002;13 Suppl 2:31-6. doi: 10.1159/000049147. Cerebrovasc Dis. 2002. PMID: 11901240 Review.

3

Image registration and subtraction to detect active T(2) lesions in MS: an interobserver study.

Tan IL, van Schijndel RA, Fazekas F, Filippi M, Freitag P, Miller DH, Yousry TA, Pouwels PJ, Adèr HJ, Barkhof F. Tan IL, et al. Among authors: fazekas f. J Neurol. 2002 Jun;249(6):767-73. doi: 10.1007/s00415-002-0712-6. J Neurol. 2002. PMID: 12111312

4

The natural course of MRI white matter hyperintensities.

Schmidt R, Schmidt H, Kapeller P, Enzinger C, Ropele S, Saurugg R, Fazekas F. Schmidt R, et al. Among authors: fazekas f. J Neurol Sci. 2002 Nov 15;203-204:253-7. doi: 10.1016/s0022-510x(02)00300-3. J Neurol Sci. 2002. PMID: 12417393 Review.

5

Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele.

Enzinger C, Ropele S, Strasser-Fuchs S, Kapeller P, Schmidt H, Poltrum B, Schmidt R, Hartung HP, Fazekas F. Enzinger C, et al. Among authors: fazekas f. Arch Neurol. 2003 Jan;60(1):65-70. doi: 10.1001/archneur.60.1.65. Arch Neurol. 2003. PMID: 12533090

6

Method for quantitative imaging of the macromolecular 1H fraction in tissues.

Ropele S, Seifert T, Enzinger C, Fazekas F. Ropele S, et al. Among authors: fazekas f. Magn Reson Med. 2003 May;49(5):864-71. doi: 10.1002/mrm.10427. Magn Reson Med. 2003. PMID: 12704769 Free article.

7

Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study.

Schmidt R, Enzinger C, Ropele S, Schmidt H, Fazekas F; Austrian Stroke Prevention Study. Schmidt R, et al. Among authors: fazekas f. Lancet. 2003 Jun 14;361(9374):2046-8. doi: 10.1016/s0140-6736(03)13616-1. Lancet. 2003. PMID: 12814718

8

Spinal-cord MRI in multiple sclerosis.

Lycklama G, Thompson A, Filippi M, Miller D, Polman C, Fazekas F, Barkhof F. Lycklama G, et al. Among authors: fazekas f. Lancet Neurol. 2003 Sep;2(9):555-62. doi: 10.1016/s1474-4422(03)00504-0. Lancet Neurol. 2003. PMID: 12941578

9

Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4.

Enzinger C, Ropele S, Smith S, Strasser-Fuchs S, Poltrum B, Schmidt H, Matthews PM, Fazekas F. Enzinger C, et al. Among authors: fazekas f. Ann Neurol. 2004 Apr;55(4):563-9. doi: 10.1002/ana.20027. Ann Neurol. 2004. PMID: 15048896

10

European study on intravenous immunoglobulin in multiple sclerosis: results of magnetization transfer magnetic resonance imaging analysis.

Filippi M, Rocca MA, Pagani E, Iannucci G, Sormani MP, Fazekas F, Ropele S, Hommes OR, Comi G. Filippi M, et al. Among authors: fazekas f. Arch Neurol. 2004 Sep;61(9):1409-12. doi: 10.1001/archneur.61.9.1409. Arch Neurol. 2004. PMID: 15364687 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

635 results

Search Page